BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kanizaj TF, Kunac N. Helicobacter pylori: Future perspectives in therapy reflecting three decades of experience. World J Gastroenterol 2014; 20(3): 699-705 [PMID: 24574743 DOI: 10.3748/wjg.v20.i3.699]
URL: https://www.wjgnet.com/1007-9327/full/v20/i3/699.htm
Number Citing Articles
1
Anthony O'Connor, Takahisa Furuta, Javier P. Gisbert, Colm O'Morain. Review – Treatment of Helicobacter pylori infection 2020Helicobacter 2020; 25(S1) doi: 10.1111/hel.12743
2
Yanqiang Huang, Xudong Hang, Xueqing Jiang, Liping Zeng, Jia Jia, Yong Xie, Fei Li, Hongkai Bi. In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori Antimicrobial Agents and Chemotherapy 2019; 63(6) doi: 10.1128/AAC.00004-19
3
Galit H. Frydman, Nick Davis, Paul L. Beck, James G. Fox. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of BiogeographyHelicobacter 2015; 20(4): 239 doi: 10.1111/hel.12200
4
Mohamed M.M. Abdel-Latif, Mekky M. Abouzied. Molecular Mechanisms of Natural Honey Against H. pylori Infection Via Suppression of NF-κB and AP-1 Activation in Gastric Epithelial CellsArchives of Medical Research 2016; 47(5): 340 doi: 10.1016/j.arcmed.2016.09.002
5
Youhua Wang, Rulin Zhao, Ben Wang, Qiaoyun Zhao, Zhen Li, Liya Zhu-ge, Wenzhu Yin, Yong Xie. Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2018; 74(1): 1 doi: 10.1007/s00228-017-2347-7
6
Vasiliy Ivanovich Reshetnyak, Alexandr Igorevich Burmistrov, Igor Veniaminovich Maev. <i>Helicobacter pylori</i>: Commensal, symbiont or pathogen? World Journal of Gastroenterology 2021; 27(7): 545-560 doi: 10.3748/wjg.v27.i7.545
7
Tássia Flores Rech, Luiz Edmundo Mazzoleni, Felipe Mazzoleni, Carlos Fernando de Magalhães Francesconi, Guilherme Becker Sander, Rafael Tomoya Michita, Débora Dreher Nabinger, Tobias Cancian Milbradt, Ronaldo João Spinato Torresini, Daniel Simon. Helicobacter pylori eradication: influence of interleukin-1beta –31 C/T polymorphismThe Brazilian Journal of Infectious Diseases 2018; 22(4): 311 doi: 10.1016/j.bjid.2018.06.005
8
Ju Yup Lee. Helicobacter pylori2016; : 437 doi: 10.1007/978-981-287-706-2_42
9
Muhammad Arif, Quan-Jiang Dong, Mazhar Ali Raja, Shah Zeenat, Zhe Chi, Chen-Guang Liu. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pyloriMaterials Science and Engineering: C 2018; 83: 17 doi: 10.1016/j.msec.2017.08.038
10
Ju Yup Lee. Helicobacter pylori2023; : 553 doi: 10.1007/978-981-97-0013-4_45
11
Zi-Wei Jing, Yi-Yang Jia, Ning Wan, Min Luo, Meng-Lei Huan, Tai-Bin Kang, Si-Yuan Zhou, Bang-Le Zhang. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pyloriBiomaterials 2016; 84: 276 doi: 10.1016/j.biomaterials.2016.01.045
12
Priscila Baptistella Yazbek, Ariane Biolcati Trindade, Chung Man Chin, Jean Leandro dos Santos. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pyloriDigestive Diseases and Sciences 2015; 60(10): 2901 doi: 10.1007/s10620-015-3712-y
13
Jingdong Rao, Yuhe Yang, Ho Pan Bei, Chak-Yin Tang, Xin Zhao. Antibacterial nanosystems for cancer therapyBiomaterials Science 2020; 8(24): 6814 doi: 10.1039/D0BM01537G
14
Hirotaka Igarashi, Shingo Maeda, Koichi Ohno, Ayako Horigome, Toshitaka Odamaki, Hajime Tsujimoto, Bryan A. White. Effect of Oral Administration of Metronidazole or Prednisolone on Fecal Microbiota in DogsPLoS ONE 2014; 9(9): e107909 doi: 10.1371/journal.pone.0107909
15
Yong Hwan Kwon. Helicobacter pylori2016; : 459 doi: 10.1007/978-981-287-706-2_45
16
Tsung-Jung Lin, Hsi-Chang Lee, Chih-Lin Lin, Chung-Kwe Wang, Kuan-Yang Chen, Deng-Chyang Wu. CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for <i>Helicobacter pylori</i> eradicationWorld Journal of Clinical Cases 2018; 6(12): 514-520 doi: 10.12998/wjcc.v6.i12.514
17
Hassan Ali Metanat, Seyed Mohammad Valizadeh, Hafez Fakheri, Iradj Maleki, Tarang Taghvaei, Vahid Hosseini, Zohreh Bari. Comparison Between 10‐ and 14‐Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical TrialHelicobacter 2015; 20(4): 299 doi: 10.1111/hel.12202
18
Varocha Mahachai, Ratha‐korn Vilaichone, Rapat Pittayanon, Jarin Rojborwonwitaya, Somchai Leelakusolvong, Monthira Maneerattanaporn, Peranart Chotivitayatarakorn, Sombat Treeprasertsuk, Chomsri Kositchaiwat, Pises Pisespongsa, Pisaln Mairiang, Aziz Rani, Alex Leow, Swe Mon Mya, Yi‐Chia Lee, Sengdao Vannarath, Bouachanh Rasachak, Oung Chakravuth, Moe Myint Aung, Tiing‐Leong Ang, Jose D Sollano, Duc Trong Quach, Inchaya Sansak, Olarn Wiwattanachang, Piyathida Harnsomburana, Ari Fahrial Syam, Yoshio Yamaoka, Kwong‐Ming Fock, Khean‐Lee Goh, Kentaro Sugano, David Graham. Helicobacter pylori management in ASEAN: The Bangkok consensus reportJournal of Gastroenterology and Hepatology 2018; 33(1): 37 doi: 10.1111/jgh.13911
19
Ayman Fathy El Sayed, Ayman Magd Eldin Mohammad Sadek, Walid Ahmed Ragab Abdelhamid. Comparison between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized TrialMiddle East Journal of Digestive Diseases 2021; 13(3): 223 doi: 10.34172/mejdd.2021.229
20
Nuno Almeida, Maria Manuel Donato, José Manuel Romãozinho, Cristina Luxo, Olga Cardoso, Maria Augusta Cipriano, Carol Marinho, Alexandra Fernandes, Carlos Calhau, Carlos Sofia. Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0245-y
21
Adel Elrakeeb, Sawsan H. Eltayyeb, Amr Elgazzar, Abdelaleem A. Elgendy, Mohamed Alboraie. Tailored Helicobacter pylori therapy is more effective than conventional therapyAl-Azhar Assiut Medical Journal 2021; 19(3): 379 doi: 10.4103/azmj.azmj_51_21
22
María Teresa Orta de Velásquez, Isaura Yáñez Noguez, Beatriz Casasola Rodríguez, Priscila Ivette Román Román. Effects of ozone and chlorine disinfection on VBNCHelicobacter pyloriby molecular techniques and FESEM imagesEnvironmental Technology 2017; 38(6): 744 doi: 10.1080/09593330.2016.1210680
23
Annika Flint, Alain Stintzi, Lígia M. Saraiva, Michael Bott. Oxidative and nitrosative stress defences ofHelicobacterandCampylobacterspecies that counteract mammalian immunityFEMS Microbiology Reviews 2016; 40(6): 938 doi: 10.1093/femsre/fuw025
24
Yong Hwan Kwon. Helicobacter pylori2023; : 575 doi: 10.1007/978-981-97-0013-4_48
25
Yong Hwan Kwon, Seong Woo Jeon, Su Youn Nam, Hyun Suk Lee, Ji Hey Park. Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single‐center prospective pilot studyHelicobacter 2019; 24(4) doi: 10.1111/hel.12585
26
Zi-Wei Jing, Min Luo, Yi-Yang Jia, Chen Li, Si-Yuan Zhou, Qi-Bing Mei, Bang-Le Zhang. Anti-Helicobacter pylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivativeInternational Journal of Biological Macromolecules 2018; 115: 367 doi: 10.1016/j.ijbiomac.2018.04.070
27
Wen-Ting Zhou, Yuan-Yuan Dai, Li-Juan Liao, Shi-Xian Yang, Hao Chen, Liang Huang, Juan-Li Zhao, Yan-Qiang Huang. Linolenic acid-metronidazole inhibits the growth of <i>Helicobacter pylori</i> through oxidationWorld Journal of Gastroenterology 2023; 29(32): 4860-4872 doi: 10.3748/wjg.v29.i32.4860